Impact of COVID ‐19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations
Clinical & Experimental Ophthalmology · 2024-05 · 52 (4) · 387-401
DOI: 10.1111/ceo.14340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 13.12.2023. Verfasst von Kwanghyun Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Eye Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Health Insurance Service Ilsan Hospital, NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL.
Abstract (Originalsprache)
Background
The coronavirus disease (COVID‐19) pandemic significantly impacted medical care, including ophthalmology. This study aimed to identify factors associated with reduced ophthalmic medical access during the pandemic.
Methods
This nationwide population‐based cohort study analysed South Korean health insurance claims data from January 2019 to November 2021. Outpatient visits and surgeries for age‐related macular degeneration, cataract, diabetic retinopathy, glaucoma, and retinal detachment during the two pandemic waves were compared with those in the non‐pandemic period. Poisson regression was used to estimate incidence rate ratios and changes in outpatient visits and surgeries between waves concerning patient age, sex, residential location, and health insurance type.
Results
Outpatient visits for five eye diseases decreased in the first wave (0.733–0.985, P < 0.001). In the second wave, only outpatient visits for age‐related macular degeneration, cataract, and glaucoma decreased (0.754, 0.878, and 0.874, respectively, all P < 0.001). Age‐related macular degeneration, cataract, and glaucoma surgeries were significantly reduced in the first wave (0.829, P < 0.001; 0.836, P < 0.001; 0.904, P = 0.030, respectively). Age‐related macular degeneration (0.852) and cataract (0.716) surgeries dropped in the second wave. Women and elderly (>65 years) patients curtailed outpatient visits and surgeries more throughout the pandemic and were less resilient during the second wave. Wave location was also related to outpatient visits and surgeries.
Conclusions
The COVID‐19 pandemic decreased outpatient visits and surgeries for eye diseases, with more significant impact on women, older patients, and those residing near wave locations. These findings can inform healthcare policies to minimise future pandemic impacts on healthcare delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
- Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Institute of Health Insurance & Clinical Research, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
ORCID-Profile: Kwanghyun Lee
Förderung
- National Health Insurance Service Ilsan Hospital
- NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL
Zitieren
APA
Lee, K., Park, Y. M., Choi, J. K., & Lee, J. (2024). Impact of COVID ‐19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations. Clinical & Experimental Ophthalmology, 52(4), 387-401. https://doi.org/10.1111/ceo.14340
Vancouver
Lee K, Park YM, Choi JK, Lee J. Impact of COVID ‐19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations. Clinical & Experimental Ophthalmology. 2024;52(4):387-401. doi:10.1111/ceo.14340
BibTeX
@article{Lee2024,
author = {Lee, Kwanghyun and Park, Young Min and Choi, Jung-Kyu and Lee, Jaekwang},
title = {Impact of COVID ‐19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations},
journal = {Clinical & Experimental Ophthalmology},
year = {2024},
volume = {52},
number = {4},
pages = {387--401},
doi = {10.1111/ceo.14340}
}
EUVIMED